Non-Current Assets
PP&E (Net)
Amgen PP&E (Net) increased by 3.8% to $8.22B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.0%, from $6.68B to $8.22B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 10.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase reflects ongoing capital expenditure and investment in future production capacity.
Detailed definition
The net book value of tangible long-lived assets such as manufacturing facilities, laboratories, and specialized equipme...
Peer comparison
High for manufacturing-heavy biotech firms; peers are compared on capital intensity ratios.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.91B | $4.98B | $5.18B | $5.14B | $5.16B | $5.19B | $5.43B | $5.46B | $5.53B | $5.56B | $5.94B | $6.00B | $6.10B | $6.16B | $6.54B | $6.68B | $6.86B | $7.22B | $7.91B | $8.22B |
| QoQ Change | — | +1.5% | +4.1% | -0.8% | +0.3% | +0.6% | +4.6% | +0.6% | +1.3% | +0.6% | +6.8% | +1.0% | +1.6% | +1.0% | +6.3% | +2.1% | +2.6% | +5.3% | +9.6% | +3.8% |
| YoY Change | — | — | — | — | +5.1% | +4.1% | +4.7% | +6.2% | +7.3% | +7.2% | +9.5% | +9.9% | +10.2% | +10.7% | +10.1% | +11.3% | +12.4% | +17.3% | +20.9% | +23.0% |
Range$4.91B – $8.22B
CAGR+11.5%
Avg YoY Growth+10.6%
Median YoY Growth+10.0%
Current Streak16 quarters growth
Geographic Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| ROW | $1.07B | $1.03B | $1.14B | $1.21B | $1.45B |
| Total | $5.18B | $5.43B | $5.94B | $6.54B | $7.91B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Amgen's pp&e (net)?
- Amgen (AMGN) reported pp&e (net) of $8.22B in Q1 2026.
- How has Amgen's pp&e (net) changed year-over-year?
- Amgen's pp&e (net) increased by 23.0% year-over-year, from $6.68B to $8.22B.
- What is the long-term trend for Amgen's pp&e (net)?
- Over 5 years (2020 to 2025), Amgen's pp&e (net) has grown at a 10.1% compound annual growth rate (CAGR), from $4.89B to $7.91B.
- What does pp&e (net) mean?
- The value of the company's physical buildings and equipment after accounting for wear and tear.